Hepatic targeting of the centrally active cannabinoid 1 receptor (CB1R) blocker rimonabant via PLGA nanoparticles for treating fatty liver disease and diabetes
| Autor: | Hirsch, Shira, Hinden, Liad, Naim, Meital Ben-David, Baraghithy, Saja, Permyakova, Anna, Azar, Shahar, Nasser, Taher, Portnoy, Emma, Agbaria, Majd, Nemirovski, Alina, Golomb, Gershon, Tam, Joseph |
|---|---|
| Zdroj: | In Journal of Controlled Release January 2023 353:254-269 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect